United States · Amendment · HAMDT
HAMDT 712 (116th)
An amendment numbered 2 printed in Part B of House Report 116-334 to require CMS to create and implement a measure in the Star Ratings program evaluating Medicare Advantage and Part D plans on how well they provide access to biosimilar drugs.
Introduced
—
Last action
—
Status
On agreeing to the Tonko amendment (A002) Agreed to by voice vote.
Sponsors
Rep. Tonko, Paul [D-NY-20]
Subjects
Discovery layer
Source updated
8 February 2022
Records
Official amendment HAMDT 712 (116th) from United States at United States Congress. Status: On agreeing to the Tonko amendment (A002) Agreed to by voice vote..
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- Rep. Tonko, Paul [D-NY-20] · D · Sponsor
Related records
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/amendment/116th-congress/hamdt-712
- Open data entity: https://api.congress.gov/v3/amendment/116/hamdt/712
- us · 116-hamdt-712 · source updated 8 February 2022